📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Targeting ERBB3 and AKT to overcome adaptive resistance in EML4-ALK non-small cell lung cancer (2024)

First Author: Bayliss R

Attributed to: A Multi-User Flow Cytometry Facility for the Biosciences in Leeds funded by BBSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.21203/rs.3.rs-3919151/v1

Publication URI: http://dx.doi.org/10.21203/rs.3.rs-3919151/v1

Type: Preprint